Related references
Note: Only part of the references are listed.Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
Sanjana Ballal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Radioligand Therapy of Prostate Cancer with a Long-Lasting Prostate-Specific Membrane Antigen Targeting Agent 90Y-DOTA-EB-MCG
Zhantong Wang et al.
BIOCONJUGATE CHEMISTRY (2018)
Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches
Nikki A. Thiele et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2018)
Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy
Edyta Cedrowska et al.
JOURNAL OF NANOPARTICLE RESEARCH (2018)
Evaluation of an Anti-HER2 Nanobody Labeled with 225AC for Targeted alpha-Particle Therapy of Cancer
Marek Pruszynski et al.
MOLECULAR PHARMACEUTICS (2018)
Gold Nanoparticles in Radiotherapy and Recent Progress in Nanobrachytherapy
Myriam Laprise-Pelletier et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with 177Lu
Zhongli Cai et al.
PHARMACEUTICAL RESEARCH (2017)
68Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy
Penelope Bouziotis et al.
NANOMEDICINE (2017)
Low-Dose Prostate Cancer Brachytherapy with Radioactive Palladium-Gold Nanoparticles
Myriam Laprise-Pelletier et al.
ADVANCED HEALTHCARE MATERIALS (2017)
An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy
Nikki A. Thiele et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Smaller Agents for Larger Therapeutic Indices: Nanoscale Brachytherapy with 177Lu-Labeled Gold Nanoparticles
Emily B. Ehlerding et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer
Simmyung Yook et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
225Ac-PSMA-617 for PSMA-Targeted a-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Sticky Patches on Lipid Nanoparticles Enable the Selective Targeting and Killing of Untargetable Cancer Cells
Michelle Sempkowski et al.
LANGMUIR (2016)
Minor changes in the macrocyclic ligands but major consequences on the efficiency of gold nanoparticles designed for radiosensitization
G. Laurent et al.
NANOSCALE (2016)
Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, 177Lu
Simmyung Yook et al.
MOLECULAR PHARMACEUTICS (2015)
Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with 177Lu and Conjugated to Peptides
Guillermina Ferro-Flores et al.
CURRENT RADIOPHARMACEUTICALS (2015)
LnPO4 Nanoparticles Doped with Ac-225 and Sequestered Daughters for Targeted Alpha Therapy
Mark F. McLaughlin et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2014)
Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls
Jihyoun Lee et al.
CANCER LETTERS (2014)
Molecular Targeting Radiotherapy with Cyclo-RGDfK(C) Peptides Conjugated to 177Lu-Labeled Gold Nanoparticles in Tumor-Bearing Mice
Andrea Vilchis-Juarez et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
DNA Double Strand Breaks as Predictor of Efficacy of the Alpha-Particle Emitter Ac-225 and the Electron Emitter Lu-177 for Somatostatin Receptor Targeted Radiotherapy
Franziska Graf et al.
PLOS ONE (2014)
The In Vivo Radiosensitizing Effect of Gold Nanoparticles Based MRI Contrast Agents
Imen Miladi et al.
SMALL (2014)
Multifunctional targeted therapy system based on 99mTc/177Lu-labeled gold nanoparticles-Tat(49-57)-Lys3-bombesin internalized in nuclei of prostate cancer cells
Nallely Jimenez-Mancilla et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2013)
The biodistribution of gold nanoparticles designed for renal clearance
Christophe Alric et al.
NANOSCALE (2013)
The journey of a drug-carrier in the body: An anatomo-physiological perspective
Nicolas Bertrand et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Role of Antibody-Mediated Tumor Targeting and Route of Administration in Nanoparticle Tumor Accumulation in Vivo
Niladri Chattopadhyay et al.
MOLECULAR PHARMACEUTICS (2012)
A Reexamination of Active and Passive Tumor Targeting by Using Rod-Shaped Gold Nanocrystals and Covalently Conjugated Peptide Ligands
Xiaohua Huang et al.
ACS NANO (2010)
In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts
Huan Xie et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Parameters influencing the stealthiness of colloidal drug delivery systems
Arnaud Vonarbourg et al.
BIOMATERIALS (2006)
Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy
RA Older et al.
JOURNAL OF UROLOGY (2001)
Share Paper
